Dabur India Q4 Review - Double-Digit Growth Momentum Continues: IDBI Capital
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
IDBI Capital Report
Dabur India Ltd.'s Q4 FY21 result was in line with our estimates.
Consolidated revenue grew 25% driven by similar levels of volume growth.
Home and personal care business continued to witness strong recovery driven by improvement in demand for discretionary products (Gulabari and FEM) and market share gains in all other segments.
In Health care business:
The company gained market share in Chyawanprash and honey.
New product developments drove revenue growth for over-the-counters while ethical segment grew strong double digit led by distribution expansion, visibility initiatives and activations.
Food and beverage business reported strong recovery in beverages while culinary portfolio continues to grow at strong double digit.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.